Park Dental Partners PARK

NASDAQ PARK
$19.39 -0.46 (-2.32%)
At close: Oct 26, 2026 · 4:00 PM EDT

Park Dental Partners (PARK) stock price is $19.39, down 2.32% on the day, as of Oct 26, 2026. It is classified in the Dental industry (Healthcare sector).

Key Stats
Add ratio to table…

About

Park Dental Partners, Inc. operates as a dental resource organization, providing comprehensive business support services to affiliated general and multi-specialty dental practices across Minnesota, Wisconsin, and Arizona. The company delivers non-clinical administrative and operational resources, including staffing, facilities, equipment, marketing, billing, and technology, enabling dentists to focus on patient care. With a network of 86 practice locations, Park Dental…

Read more ↓
Sector: Healthcare Sector rationale The company operates as a dental resource organization that generates the vast majority of its revenue from the provision of general and specialty dental services (e.g., oral surgery, periodontics, and pediatric dentistry). Its primary customers are patients seeking medical care, and its revenue is largely derived from insurance plans and patient payments for these healthcare services. Industry: Dental Dental Primary Park Dental Partners operates as a dental resource organization supporting a network of 86 practice locations providing general and specialty dentistry. Its revenue is derived from dental services including cleanings, fillings, oral surgery, and orthodontics. Classified using BQ-MICS CIK: 0002069604
Bull & bear

Investment Thesis

▲ Bull case
  • Park Dental Partners demonstrates a resilient growth foundation with consistent patient retention above 90% and 6.2% year-over-year revenue growth in Q1 FY26, driven by organic patient demand and strategic provider base expansion, indicating strong underlying demand for dental services that remains insulated from broader macroeconomic pressures as explicitly stated by management when noting no observable changes in patient behavior despite higher oil prices and inflation, suggesting the defensive nature of essential healthcare spending could support steady same-practice growth even in uncertain economic climates.
  • The company's disciplined M&A strategy, prioritizing cultural fit and long-term value creation over short-term deal velocity, combined with a substantially expanded acquisition pipeline featuring opportunities across solo practices to larger groups, positions Park Dental to capitalize on market fragmentation in dental services, where consolidation remains in early stages and integrated specialty care deployment—already underway in Arizona with practice management system conversion within weeks—can unlock significant operating leverage and cross-selling potential as scale increases.
  • Park Dental's focus on expanding clinical capacity through strategic hiring of new graduates and increased provider hours, coupled with management's confidence in continued doctor count growth throughout 2026 despite typical summer hiring seasonality, signals sustainable organic growth drivers that are underappreciated by the market, particularly as the company leverages its patient-first culture and doctor-centric governance to enhance retention and satisfaction, which directly supports pricing power and service expansion without aggressive marketing spend.
  • The upcoming rollout of integrated specialty care services across newly acquired markets, beginning with Arizona and planned expansion into two to three new markets over the next few years via a land-and-expand playbook, represents a structural shift toward higher-margin, comprehensive care offerings that could significantly improve adjusted EBITDA margins beyond the current 7.6% as specialized services typically command higher reimbursement rates and increase patient lifetime value, a catalyst management acknowledged as a larger growth lever than de novo openings but did not emphasize in forward guidance.
▼ Bear case
  • Park Dental Partners reported a GAAP net loss of $0.4 million in Q1 FY26, a significant deterioration from $1.6 million net income in Q1 FY25, primarily driven by non-cash share-based compensation expenses from IPO vesting triggers affecting 91% of doctor shareholders, which, while expected, creates persistent GAAP profitability pressure that may distort investor perception of underlying earnings power and could lead to unjustified valuation discounts if the market fails to fully adjust for these temporary, non-cash impacts despite management's transparency about their declining trajectory over remaining quarters.
  • The company's reliance on acquiring practices as the primary growth lever—explicitly stated by CFO CJ Bernander as the 'larger lever' compared to de novo openings—exposes Park Dental to execution risk in a competitive M&A environment where cultural fit assessments may slow deal flow, integration costs could exceed expectations as seen in Arizona where practice management system conversion is ongoing, and overpayment for targets becomes likely if competition intensifies, particularly given the lack of disclosed future de novo activity which limits near-term organic growth visibility.
  • Revenue growth is increasingly dependent on expanding clinical capacity through hiring and hour expansion rather than fee increases or pricing power, as evidenced by same-practice growth of only 4.1% driven by patient visits and clinical hours rather than reimbursement growth, suggesting limited ability to raise prices in a potentially price-sensitive market despite strong patient retention, which could constrain margin expansion if wage inflation or supply costs outpace revenue growth from volume alone.
  • The company's outlook for Q2 FY26 revenue growth to be lower than Q1, with acceleration only expected in H2 due to seasonal hiring patterns and integration timelines from year-end 2025 acquisitions, creates near-term growth volatility that may lead to quarterly earnings inconsistency, undermining investor confidence in predictable performance and potentially resulting in multiple compression if the market perceives the business as highly seasonal or dependent on uneven acquisition timing rather than steady, scalable organic growth.
Peer group

Peer Comparison

Companies in the Dental
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 TMO Thermo Fisher Scientific Inc. 254.18 Bn36.485.4942.55 Bn
2 ABT Abbott Laboratories 182.26 Bn33.603.9132.61 Bn
3 DHR Danaher Corp /De/ 164.19 Bn41.016.5426.56 Bn
4 ISRG Intuitive Surgical Inc 157.75 Bn53.3413.62-
5 MDT Medtronic plc 121.22 Bn23.173.2328.15 Bn
6 SYK Stryker Corp 117.53 Bn31.524.5514.94 Bn
7 BSX Boston Scientific Corp 67.04 Bn18.243.1912.62 Bn
8 BDX Becton Dickinson & Co 53.87 Bn57.242.3216.81 Bn